Clinical Trial 45684

Austin, TX 78750


Study 45684 Flyer
Click image to enlarge

This study will evaluate intravitreal injections of investigational drug in participants with geographic atrophy (GA) secondary to age-related macular degeneration (AMD) compared with sham control. After completing the study's last visit (Week 76), eligible participants will have the option to enroll in an open-label extension study and receive open-label investigational drug injections.

Qualified Participants Must:

• Be 60 years of age or older at time of consent
• Have geographic atrophy secondary to age-related macular degeneration
• Have visual acuity of 20/320 or better in the study eye
• Not have active cancer in the past 12 months
• Not have any other eye condition other than dry AMD causing vision loss

Qualified Participants May Receive:

1). Reimbursement for their time

2). Transportation assistance

3). Study related care and investigational drug at no cost

Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.